loberamisal
Jump to navigation
Jump to search
Indications
- acute ischemic stroke (investigational)
Dosage
- 40 mg daily for 10 days
Mechanism of action
- inhibits PSD-95 - neuronal nitric oxide synthase interaction
- selectively potentiates alpha-2 GABA A receptors
- dual antidepressant-anxiolytic
More general terms
References
- ↑ Lou N Neuroprotective Agent Improved Outcomes After Acute Ischemic Stroke. The PSD-95 inhibitor also had a favorable safety profile in phase III trial. MedPage Today. February 6, 2026 https://www.medpagetoday.com/meetingcoverage/isc/119779